Navigation Links
Citius Tech Launches BI-Clinical MUSE for Advanced "Meaningful Use" Reporting and Data Submission, and Performance Management for Healthcare ISVs
Date:3/1/2010

SARASOTA, Florida, March 1, 2010 /PRNewswire/ -- Citius Tech, a leading provider of healthcare technology solutions and services, announced today the launch of BI-Clinical MUSE - an enhanced version of its healthcare business intelligence framework - BI-Clinical - for "Meaningful Use" Analytics & Reporting compliance.

The BI-Clinical framework provides an integrated approach for clinical, operational, financial and regulatory performance management in healthcare for hospitals, physician practices and managed care organizations - covering over 600 measures. BI-Clinical hospital module includes acute care reporting (e.g., AMI, pneumonia and stroke) and measures for CMS, JCAHO, P4P, and NCQA. Similarly, BI-Clinical physician practice module includes registry-based reporting for chronic diseases such as diabetes, hypertension, COPD, CAD as well as measures for PQRI and DOQ-IT.

The recent "meaningful use" requirements published by HHS mandate clinical quality reporting measures for hospitals and physician practices. Citius Tech has customized the BI-Clinical framework for "meaningful use" - BI-Clinical MUSE - to cover all reporting requirements for hospitals (443 measures in 2011) and physician practices (90 measures in 2011). BI-Clinical MUSE also supports public health data submission.

"The meaningful use guidelines impose significant technology & reporting requirements for healthcare ISVs and care providers" said Bimal R. Naik, Senior Vice President at Citius Tech. "BI-Clinical MUSE is designed as a modular framework which can be bundled with EHRs and other clinical applications. Microsoft's Business Intelligence stack provides a highly flexible and scalable deployment platform for BI-Clinical."

"Hospitals and health organizations are faced with an abundance of quality measures that they must report on," said Chris Sullivan, U.S. health provider industry solutions director, Microsoft. "Citius Tech's BI-Clinical framework, based on the Microsoft Business Intelligence platform, helps healthcare organizations with this quality measures reporting."

About Citius Tech

Citius Tech (http://www.citiustech.com ) is a specialist provider of technology solutions and services to healthcare technology companies, providers, MCOs, and health plans. Citius Tech practice areas include healthcare software engineering, healthcare interoperability, healthcare business intelligence and CRMM. Citius Tech brings strong healthcare domain expertise - across technologies, applications and standards. Thee ability to provide this expertise, together with world-class service quality and a global resource base , enables Citius Tech to offer a distinctive value proposition to our clients.

    Product and company names herein may be the trademarks of their
respective owners.

    Citius Tech Inc.
    Amar Badlani
    amarb@cittiustech.com
    Off: +1-36-0-326-8060

SOURCE Citius Tech Inc

Back to top
'/>"/>
SOURCE Citius Tech Inc
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Dalton Pharma Services and ProCitius Announce a Strategic Alliance to Provide Contract Chemistry Services
2. Research Triangle Area Health Care Collaborative Launches Bridges to Excellence(R) Initiative to Improve Quality and Lower Costs
3. Novozymes Launches Enzyme to Reduce Acrylamide in Food
4. Enova Medical Launches Exos Corporation
5. Elekta Launches New Linear Accelerator at 2007 ESTRO to Expand Cancer Treatment Availability
6. Signalifes Dr. Harmison Launches Award-Winning Ambulatory Heart Monitor
7. ThirdBiotech Networking Group Launches
8. BioReliance Launches Next-Generation Genotoxicity Screening Service
9. Midwest Research Institute Launches Center for Biological Safety and Security (CBS2)
10. BioReliance Corporation Launches iNet(TM) for Online Results Tracking of Biological Safety Tests
11. Kingfisher Healthcare Launches Breakthrough Product in Europe
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... 2017  Driven by consumers, preference towards more ... fastest growing categories, finds the recently published U.S. ... Care: Multi-regional Market Analysis and Opportunities study ... Kline. "Biotechnology actives are derived from ... effective for skin and hair care applications," explains ...
(Date:2/24/2017)... 2017  OncoSec Medical Incorporated ("OncoSec") (NASDAQ: ONCS), a ... Key Opinion Leader event to highlight new clinical data ... presentation at the upcoming 2017 ASCO-SITC Immuno-Oncology Symposium and ... be held in-person and via live webcast on Tuesday, ... PST at the Lotte New York Palace Hotel in ...
(Date:2/23/2017)... 23, 2017  MIODx announced today that it ... immunotherapy technologies from the University of California, San ... to monitor a patient for response to immune ... The second license extends the technology with a ... to have an immune-related adverse event (IRAE) from ...
(Date:2/23/2017)... , ... February 23, 2017 ... ... announced today that in a published evaluation of multiple immunoassay-based threat detection ... Department of Energy Laboratory, PathSensors’ CANARY® biosensor threat detection technology was found ...
Breaking Biology Technology:
(Date:2/21/2017)... LONDON , February 21, 2017 ... um 70 Millionen US-Dollar wachsen. Nach einem Gespräch mit mehr ... es einige Hindernisse zu überwinden gilt, um diese Prognose ... ... unter anderem die Mobilisierung der finanziellen Mittel für die ...
(Date:2/13/2017)... , Feb. 13, 2017 Former 9/11 Commission ... Judiciary Committee, Janice Kephart of Identity Strategy ... Donald Trump,s "Executive Order: Protecting the Nation ... 27, 2017):  "As President Trump,s ,Travel Ban, ... has now essentially banned the travel ban, it is ...
(Date:2/8/2017)... 7, 2017  Aware, Inc. (NASDAQ: AWRE ), ... financial results for its quarter and year ended December 31, ... 2016 was $3.9 million compared to $6.9 million in the ... of 2016 was $0.6 million compared to $2.6 million in ... quarter of 2016 was $0.5 million, or $0.02 per diluted ...
Breaking Biology News(10 mins):